🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Remimazolam is a novel drug approved for induction and maintenance of gener...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2021-11-01
Trial ID
NCT05025410
Treatments Being Tested
The bispectral index (BIS) monitoring is an EEG-based method that uses elec...
Status
Unknown
Location
Multiple Locations
Start Date
2017-04-15
Trial ID
NCT03114774
Treatments Being Tested
The primary objective of this observational study is to evaluate the effect...
Status
Completed
Location
Ankara University
Start Date
2024-01-25
Trial ID
NCT06644209
Fentanyl is analgesia medication. There has not pain nerve in the lung. Fle...
Status
Unknown
Location
Multiple Locations
Start Date
2016-07-21
Trial ID
NCT03395093
Treatments Being Tested
Recovery and emergence agitation is a problem that occurs after anesthesia ...
Status
Unknown
Location
Kocaeli City Hospital
Start Date
2023-12-29
Trial ID
NCT06217341
Treatments Being Tested
Postoperative cognitive disorders, including postoperative cognitive dysfun...
Status
Completed
Location
Ankara University Faculty of Medicine
Start Date
2023-09-27
Trial ID
NCT07509372
Treatments Being Tested
Objective Endoscopic Retrograde Cholangiopancreatography (ERCP) is performe...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02792751
Treatments Being Tested
The purpose of this study is to use the BIS monitor to assess the degree of...
Status
Completed
Location
University Hospital Ghent
Start Date
2013-03-01
Trial ID
NCT01768416
The aim of this study was to assess the clinical performance of two differe...
Status
Completed
Location
Hospital Santa Sofia
Start Date
2009-09
Trial ID
NCT01011192
Aim of this trial is to define if Concentration at the effector site (Ce) o...
Status
Completed
Location
ULSS 2 Marca Trevigiana
Start Date
2022-03-31
Trial ID
NCT05288764
Treatments Being Tested